The head of the Endocrinology and Metabolism Research Institute at Shahid Beheshti University of Medical Sciences stated: New weight loss drugs are very useful and should be used in many cases; however, the excessive use of these drugs is also a challenge.
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding.
See what Iranian state media is saying today.
❓ Unknown
New Weight Loss Drugs Are Beneficial, But Should Not Be Used Excessively
Sep 27, 2026
September 27, 2026
1 min read
📰 ISNA
📋 Key Takeaway
The head of a medical research institute in Iran emphasizes the benefits of new weight loss drugs while warning against their excessive use. This highlights the importance of responsible medication practices in addressing obesity. It matters because it reflects ongoing health concerns in Iran.
🔍 Quick Context Guide
💡 Bottom Line:
Responsible use of weight loss drugs is crucial for managing obesity effectively in Iran.
👥 Key Players
Head of the Endocrinology and Metabolism Research Institute
MENTIONED
Medical expert
"They provide authoritative insights on health issues, particularly obesity, which is a growing concern in Iran."
Shahid Beheshti University of Medical Sciences
MENTIONED
Academic institution
"This institution is involved in medical research and education, influencing health policies and practices in Iran."
📰 What Happened
The head of a medical research institute in Iran highlighted the benefits of new weight loss drugs while cautioning against their excessive use. This statement underscores the need for responsible medication practices in addressing obesity.
- New weight loss drugs are considered beneficial for treating obesity.
- Excessive use of these drugs poses health risks.
💡 Why It Matters
🇮🇷 For Iran: This highlights the need for effective health policies and responsible drug use in managing obesity, a significant health issue in Iran.
🌍 Regional: Other countries in the region may face similar health challenges, making this a relevant discussion for broader regional health policies.
🌐 International: The global pharmaceutical market may see increased interest in weight loss drugs, raising questions about regulation and health practices.
📚 Background
Obesity is a growing health concern worldwide, including in Iran, where lifestyle changes have contributed to rising rates. New medications offer potential solutions but require careful management.
Obesity epidemic
Pharmaceutical regulations
📡 Source:
NEUTRAL
📊 Confidence:
70%
The statement comes from a reputable medical expert, suggesting a focus on health rather than political agendas.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%
📰 Related Coverage
Just now •
Trump: Negotiations with Iran are progressing well but are not trustworthy
14 min ago •
Bolsonaro Has Fled Brazil with the Help of a Former Mossad Agent
20 min ago •
Why Do Some People See Spirits or Sense the Presence of an Invisible Being?
38 min ago •
The Necessity of Public Cooperation with Energy Consumption Management Programs/The Government Must Take Optimization Seriously
44 min ago •